Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × entinostat × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Urinary Bladder Neoplasms 2 Recurrence 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Penile Neoplasms 1 Oropharyngeal Neoplasms 1 Neuroendocrine Tumors 1 Melanoma 1 Lymphoma 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms, Male 1 Brain Neoplasms 1 Anus Neoplasms 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

X-Rays 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Biopsy 4 ulixertinib 2 tipifarnib 2 selpercatinib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 Melphalan 2 Etoposide 2 trioctyl phosphine oxide 1 thymoglobulin 1 temsirolimus 1 tazemetostat 1 talazoparib 1 palbociclib 1 olaparib 1 irinotecan sucrosofate 1 fludarabine phosphate 1 amino-acid, glucose, and electrolyte solution 1 Vincristine 1 Vemurafenib 1 Transplantation 1 Topotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡